Eli Lilly Company
Records under this name other than patents Eli Lilly Company holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,044,090 | N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor Term ended Ended no later than Mar 15, 2022 · From the USPTO record | Term ended | Ended no later than Mar 15, 2022 | From the USPTO record |
| US 6,114,320 | Therapeutic treatment for VEGF related ocular diseases Term ended Term ended Apr 30, 2017 · From the USPTO record | Term ended | Term ended Apr 30, 2017 | From the USPTO record |
| US 6,849,650 | Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds Lapsed on the fee record Ended Feb 1, 2017 · From the USPTO record | Lapsed on the fee record | Ended Feb 1, 2017 | From the USPTO record |
| US 7,101,843 | Glucagon-like peptide-1 analogs Lapsed on the fee record Ended Sep 5, 2014 · From the USPTO record | Lapsed on the fee record | Ended Sep 5, 2014 | From the USPTO record |
| US 6,506,782 | Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds Lapsed on the fee record Ended Jan 14, 2011 · From the USPTO record | Lapsed on the fee record | Ended Jan 14, 2011 | From the USPTO record |
| US 6,476,263 | Compounds for inhibiting &bgr;-amyloid peptide release and/or its synthesis Lapsed on the fee record Ended Nov 5, 2010 · From the USPTO record | Lapsed on the fee record | Ended Nov 5, 2010 | From the USPTO record |
| US 6,444,641 | Fatty acid-acylated insulin analogs Lapsed on the fee record Ended Sep 3, 2006 · From the USPTO record | Lapsed on the fee record | Ended Sep 3, 2006 | From the USPTO record |
| US 4,380,641 | Insecticidal oxazolyl ureas Term ended Term ended no later than Apr 19, 2003 · Low confidence | Term ended | Term ended no later than Apr 19, 2003 | Low confidence |
| US 4,382,090 | N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds Term ended Term ended no later than May 3, 2003 · Low confidence | Term ended | Term ended no later than May 3, 2003 | Low confidence |
| US 4,534,758 | Controlled release infusion system Term ended Term ended no later than Aug 13, 2005 · Low confidence | Term ended | Term ended no later than Aug 13, 2005 | Low confidence |